University of Calgary-born Parvus Therapeutics has inked an $800m deal with Genentech to develop and commercialise treatments for autoimmune diseases.
Half a year after raising $500m in a TUS Holdings-backed series B round, the electric car developer is seeking another $500m before it floats.
Telematics system developer and MIT spinout Cambridge Mobile Telematics has raised $500m from Vision Fund that will be used for product development.
Investors in the series B round included TUS Holdings, FAW and Contemporary Amperex Technology.
Intel invests $1.5bn for a 20% stake in Spreadtrum Communications and RDA Microelectronics.